US: +1 646-781-8004 | Europe:+44-203-868-8738 | APAC:+91-744-778-0008

Plasma Therapy Market

Release date:

Nov-2021

Region:

global

Research Code:MRHC -104530

Sku:MRHC -104530

Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes) - Global Forecast to 2028

  • Report ID: MRHC -104530
  • Pages: 169
  • Nov-2021
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours
COVID-19

This report provides pre & post COVID-19 market estimates.

The Plasma Therapy Market is expected to grow at a CAGR of 12.2% during the forecast period to reach $882.5 million by 2028. The growth of this market is mainly attributed to factors such as the advantages offered by PRP treatment, increasing awareness towards PRP therapies; the rising prevalence of musculoskeletal, sports, & orthopedic injuries; and the growing number of cosmetic procedures worldwide.

In addition, increasing PRP treatments and advancing healthcare in emerging economies are likely to offer significant growth opportunities for platelet rich plasma therapy providers.

However, the availability of alternatives for PRP treatment and side-effects associated with PRP is expected to restrain the growth of the platelet rich plasma therapy market to some extent during the forecast period. Also, the stringent regulatory framework for PRP use is the major challenging factor observed in this market.

Plasma Therapy Market

                                                                     Click here to: Get Free Sample Pages of this Report 

Impact of COVID-19 Pandemic on the Plasma Therapy Market

The outbreak of the COVID-19 pandemic and the lockdowns implemented by governments to control the spread of the disease impacted various industries. The upsurge of COVID-19 infected patients affected the management of hospitals due to its limited resources and staff compared to the sudden growth in the number of infected patients, which led to a delay in some of the surgeries and medical procedures. The procedures that were not life-threatening were delayed, and medical procedures that would have severely impacted patients and even caused loss of life if not carried out were prioritized.

The platelet-rich plasma (PRP) is mainly used in cosmetics, dermatology, orthopedics, dental procedures & oral surgeries, and sports medicine. The disorders and treatments associated with these problems are usually non-life-threatening. Therefore, PRP treatments to patients with these medical requirements were not prioritized. For instance, according to the American Society of Plastic Surgeons (ASPS), the PRP procedures for cosmetics in the U.S. fell to 231,140 procedures in 2020, from 275,101 procedures in 2019, with a decline of 16%.

Manufacturers, business owners, and suppliers of PRP therapy products within Asian economies were impacted severely by the rapid growth in the number of patients. During the outbreak, low- and middle-income countries faced more challenges due to underdeveloped health infrastructures and restrictions imposed by the authorities on suppliers and industries. The pandemic led to a significant decrease in PRP demand in regenerative medicine and pain management such as, tennis elbow, arthritis, torn ligaments, and cosmetic & plastic surgeries.

 Lockdowns were implemented worldwide to stop the transmission of the disease. The implementation of lockdown and other preventative measures impacted the supply chain and the availability of medical devices. It also affected the revenue of the companies and led to an increase in unemployment. For instance, according to a statement given by Tricell Bio, a manufacturer of PRP kits based in India, COVID-19 has impacted the business across all the industries and hopes to recover from the setback soon.

The COVID-19 outbreak severely impacted the countries in the Southeast Asian region as several countries from this region depend on export and tourism for revenue generation. Also, medical tourism suffered significant losses due to travel restrictions. For instance, according to the Malaysian Health Tourism Council (MHTC), medical tourism in the country reported a decline by 75% in revenues in 2020 ($120 million) compared to 2019. The negative impact on health tourism due to the pandemic resulted in the decrease in the adoption of PRP treatments, decreasing the usage of PRP products.

Key Findings in the Global Plasma Therapy Market Study

The Leukocyte-rich PRP Segment Expected to Grow at the Highest CAGR During Forecast Period

Based on type, the global platelet rich plasma market is segmented into pure PRP, leukocyte–rich PRP, pure platelet-rich fibrin, and leukocyte and platelet rich fibrin. In 2021, the pure PRP segment is estimated to account for the largest share of the global platelet rich plasma therapy market. Little or no risks associated with pure PRP and its ability to accelerate the healing process of tissue, tendons, and bones are the factors driving the demand for pure PRP in the market. On the other hand, the increasing use of L-PRP in patients suffering from osteoarthritis of the knee and hips and positive effects of L-PRP in certain medical applications for therapeutic purposes are expected to account for the high growth of the leukocyte–rich PRP segment during the forecast period.

The Dermatology and Cosmetology Segment Expected to Grow at the Highest CAGR During Forecast Period

Based on application, the global platelet rich plasma market is segmented into orthopedics & traumatology, rheumatology, dermatology & cosmetology, ophthalmology, stomatology & odontology, and other applications. The dermatology & cosmetology segment is expected to grow at the highest CAGR during the forecast period. The rising number of patients with skin and hair-related conditions, growing beauty consciousness amongst the general population, and increasing adoption of microneedling for cosmetic purposes support the market growth of this segment.

The Hospitals & Clinics Segment Estimated to Account for the Largest Share of Global PRP Therapy Market in 2021

Based on end user, the global platelet rich plasma therapy market is segmented into hospitals & clinics and research institutes. In 2021, the hospitals & clinics segment is estimated to account for a larger share of the global platelet rich plasma therapy market. The large share of this segment is attributed to factors such as the increase in healthcare spending and growing awareness and prescriptions for PRP treatments and procedures to patients for various medical conditions.

North America Estimated to Account for Largest Share of Global PRP Therapy Market in 2021

Based on geography, the PRP therapy market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2021, North America is estimated to account for the largest share of the global PRP therapy market. The region’s largest market share is primarily attributed to the presence of leading platelet rich plasma therapy product manufacturers, growing awareness toward advantages of platelet rich plasma therapies, active involvement of academic and research institutes to conduct advanced research and development, and support from government and regulatory authorities to promote the use of PRP for medical applications.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments that market participants adopted over the past four years. The key players profiled in the global platelet-rich plasma therapy market report include Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.).

Scope of the Report:

Platelet Rich Plasma Therapy Market, by Type

  • Pure Platelet-rich Plasma
  • Leukocyte-rich PRP
  • Platelet-rich Fibrin
  • Leukocyte & Platelet-rich Fibrin

Platelet Rich Plasma Therapy Market, by Application

  • Orthopedics and Traumatology
  • Dermatology and Cosmetology
  • Rheumatology
  • Stomatology and Odontology
  • Ophthalmology
  • Others

Platelet Rich Plasma Therapy Market, by End User

  • Hospitals and Clinics
  • Research Institutes

Platelet Rich Plasma Therapy Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of LATAM (RoLATAM)
  • Middle East & Africa

Key questions answered in the report:

What is the Focus of the Global Platelet Rich Plasma Therapy Market?

The platelet-rich plasma therapy market covers the market size & forecasts the various PRP therapy types used by hospitals & clinics and academics & research institutes for applications such as orthopedics and traumatology, dermatology & cosmetology, rheumatology, stomatology & odontology, ophthalmology, and others. The platelet rich plasma therapy market studied in this report involves the value analysis of various segments and sub-segments of PRP types at the regional and country levels.

What is the Value of Revenue Generated from PRP Therapies Across the Globe? At What Rate is Their Demand Expected to Grow for the Next 5–7 years?

The global platelet-rich plasma (PRP) therapy market is expected to grow at a CAGR of 12.2% during the forecast period to reach $882.5 million by 2028.

Which Type Segment is Estimated to Hold the Major Share of the Market?

The global plasma therapy market is segmented into pure PRP, leukocyte & platelet rich plasma, pure platelet-rich fibrin, and leukocyte & platelet rich fibrin. In 2021, the pure PRP segment is estimated to account for the largest share of the global platelet rich plasma therapy market. Pure PRP is concentrated from the patient’s blood and contains healing elements such as stem cell signal markers and growth factors.

What are the Key Factors Supporting the Growth of this Market? Also, What are the Major Opportunities for Existing Market Players and New Entrants in the Global Platelet Rich Plasma Therapy Market?

The growth of this market is mainly attributed to factors such as the advantages offered by PRP treatment, growing awareness towards PRP therapies, rising prevalence of musculoskeletal, sports, & orthopedic injuries, and the growing number of cosmetic procedures worldwide. Additionally, increasing PRP treatments and advancing healthcare in emerging economies is expected to offer significant growth opportunities for platelet rich plasma therapy providers and existing market players operating in this market.

Who are the Major Players Operating in the Global Platelet Rich Plasma Market?

Key companies operating in the global platelet rich plasma therapy market are Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.).

Which Regions/Countries are Expected to Offer Significant Growth Opportunities for Players Operating in the Platelet Rich Plasma Therapy Market?

Emerging economies like China and India are projected to offer significant growth opportunities for players in this market. Improvements in healthcare infrastructures, increasing research and development activities, and growing number of patients suffering from orthopedic and musculoskeletal disorders are expected to offer significant growth opportunities for market players operating in this region.

1.    Introduction
       1.1.    Market Definition
       1.2.    Market Ecosystem
       1.3.    Currency
       1.4.    Key Stakeholders

2.    Research Methodology
       2.1.    Research Process
       2.2.    Data Collection & Validation
                 2.2.1.    Secondary Research
                 2.2.2.    Primary Research
       2.3.    Market Assessment
                 2.3.1.    Market Size Estimation
                              2.3.1.1.    Bottom-Up Approach
                              2.3.1.2.    Top-Down Approach
                              2.3.1.3.    Growth Forecast
                 2.3.2.    Market Share Analysis
       2.4.    Assumptions for this Study
       2.5.    Limitations for the Study

3.    Executive Summary

4.    Market Insights
       4.1.    Drivers
                 4.1.1.    Advantages Offered by PRP Treatment
                 4.1.2.    Increasing Awareness Toward PRP Therapies
                 4.1.3.    Rising Prevalence of Musculoskeletal and Sports Injuries
                 4.1.4.    Growing Number of Cosmetic Procedures Worldwide
       4.2.    Restraints
                 4.2.1.    Availability of Alternatives for PRP Treatment
                 4.2.2.    Side-Effects Associated with the Use of PRP
       4.3.    Opportunities
                 4.3.1.    Increasing Applications of PRP Treatments 
                 4.3.2. Advancing Healthcare in Emerging Economies 
       4.4.    Challenge
                 4.4.1. Stringent Regulatory Framework for the Use of PRP
       4.5.    Porter’s Five Forces Analysis
                 4.5.1.    Bargaining Power of Suppliers
                 4.5.2.    Bargaining Power of Buyers
                 4.5.3.    Threat of Substitutes
                 4.5.4.    Threat of New Entrants
                 4.5.5.    Competitive Rivalry

5.    Impact of COVID-19 on the Global Platelet Rich Plasma Market

6.    PRP Qualification Criteria

7.    PRP Therapy Market Trends

8.    Platelet Rich Plasma Therapy Market, by Type
       8.1.    Introduction
       8.2.    Pure PRP
       8.3.    Leukocyte-Rich PRP
       8.4.    Pure Platelet Rich Fibrin
       8.5.    Leukocyte And Platelet Rich Fibrin (L-PRF)

9.    Platelet Rich Plasma (PRP) Therapy Market, by Application
       9.1.    Introduction
       9.2.    Orthopedics & Traumatology
       9.3.    Rheumatology
       9.4.    Dermatology & Cosmetology
       9.5.    Opthalmology
       9.6.    Stomatology & Odontology
       9.7.    Other Applications

10.   Platelet Rich Plasma Therapy Market, by End User
           10.1.    Introduction
           10.2.    Hospitals & Clinics
           10.3.    Research Institutes

11.    Platet Rich Plasma Therapy Market, by Geography
           11.1.    Introduction
           11.2.    North America
                       11.2.1.    U.S.
                       11.2.2.    Canada
           11.3.    Europe
                       11.3.1.    Germany
                       11.3.2.    France
                       11.3.3.    U.K.                       
                       11.3.4.    Italy
                       11.3.5.    Spain
                       11.3.6.    Rest of Europe (RoE)
           11.4.    Asia-Pacific
                       11.4.1.    Japan
                       11.4.2.    China
                       11.4.3.    India
                       11.4.4.    Rest of Asia-Pacific (RoAPAC)
           11.5.    Latin America
                       11.5.1.    Brazil
                       11.5.2.    Mexico
                       11.5.3.    Argentina
                       11.5.4.    Rest of Latin America
           11.6.    Middle East & Africa

12.    Competitive Landscape
           12.1.    Introduction
           12.2.    Key Growth Strategies
           12.3.    Market Share Analysis (2020)
                      12.3.1.    DePuy Synthes, Inc. (U.S.)
                      12.3.2.    Stryker Corporation (U.S.)
                      12.3.3.    Zimmer Biomet Holdings, Inc. (U.S.)
                      12.3.4.    Terumo Corporation (Japan).
           12.4.    Key Players SWOT Analysis
                      12.4.1.    Zimmer Biomet Holdings, Inc.
                                    12.4.1.1. Strengths
                                    12.4.1.2. Weaknesses
                                    12.4.1.3. Opportunities
                                    12.4.1.4. Threats
                      12.4.2.    Terumo Corporation
                                    12.4.2.1. Strengths
                                    12.4.2.2. Weaknesses
                                    12.4.2.3. Opportunities
                                    12.4.2.4. Threats
                      12.4.3.    Arthrex, Inc.
                                    12.4.3.1. Strengths
                                    12.4.3.2. Weaknesses
                                    12.4.3.3. Opportunities
                                    12.4.3.4. Threats
                       12.4.4.    DePuy Synthes, Inc. (Johnson &Johnson)
                                    12.4.4.1. Strengths
                                    12.4.4.2. Weaknesses
                                    12.4.4.3. Opportunities
                                    12.4.4.4. Threats
                      12.4.5.    Stryker Corporation
                                    12.4.5.1. Strengths
                                    12.4.5.2. Weaknesses
                                    12.4.5.3. Opportunities
                                    12.4.5.4. Threats
           12.5.    Funding and Grants Assessment

13.    Company Profiles
           13.1.    Arthrex, Inc.
                     13.1.1.    Business Overview
                     13.1.2.    Product Portfolio
                     13.1.3.    Strategic Developments
           13.2.   DePuy Synthes, Inc. (Johnson &  Johnson)
                     13.2.1.    Business Overview
                     13.2.2.    Financial Overview
                     13.2.3.    Product Portfolio
           13.3.    Dr PRP USA LLC
                     13.3.1.    Business Overview
                     13.3.2.    Product Portfolio
           13.4.   Emcyte Corporation
                     13.4.1.    Business Overview
                     13.4.2.    Product Portfolio
                     13.4.3.    Strategic Developments
           13.5.   Exactech, Inc.
                     13.5.1.    Business Overview
                     13.5.2.    Financial Overview
                     13.5.3.    Product Portfolio
           13.6.   Global Stem Cells Group, Inc.
                     13.6.1.    Business Overview
                     13.6.2.    Product Portfolio
                     13.6.3.    Strategic Developments
           13.7.   Celling Biosciences, Inc
                     13.7.1.    Business Overview
                     13.7.2.    Product Portfolio
           13.8.   Terumo Corporation
                     13.8.1.    Business Overview
                     13.8.2.    Financial Overview
                     13.8.3.    Product Portfolio
           13.9.   Regen Lab SA
                     13.9.1.    Business Overview
                     13.9.2.    Product Portfolio
           13.10.  Stryker Corporation
                     13.10.1.    Business Overview
                     13.10.2.    Financial Overview
                     13.10.3.    Product Portfolio
                     13.10.4.    Strategic Developments
           13.11. Zimmer Biomet Holdings, Inc.
                     13.11.1.    Business Overview
                     13.11.2.    Financial Overview
                     13.11.3.    Product Portfolio
           13.12.  Juventix Regenerative Medical, Llc
                     13.12.1.    Business Overview
                     13.12.2.    Product Portfolio

14.    Appendix
           14.1.    Questionnaire
           14.2.    Available Customization

List of Tables

Table 1    Platelet Rich Plasma (PRP) Therapy Market Drivers: Impact Analysis (2021–2028)
Table 2    Top Five Non-Surgical Cosmetic Procedures Performed Worldwide In 2019 and Change As Compared to 2018:
Table 3    Platelet Rich Plasma (PRP) Therapy Market Restraints: Impact Analysis (2021–2028)
Table 4    Products and Their PRP Concentrations of Some of The Leading Companies in the PRP Therapy Market
Table 5    Current Indications for Which PRP Therapy Is Used
Table 6    Ongoing Research in New Medical Fields Regarding PRP Therapy
Table 7    Global Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 8    Global Pure PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9    Global Leukocyte-Rich PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 10    Global Pure Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11    Global Leukocyte and Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 13    List of Clinical Trials with PRP for Orthopedic Applications
Table 14    Key Players offering Platelet Rich Plasma (PRP) Therapy for Orthopedics & Traumatology
Table 15    Platelet Rich Plasma (PRP) Therapy Market Size for Orthopedics & Traumatology, by Country/Region, 2019–2028 (USD Million)
Table 16    Key Players offering Platelet Rich Plasma (PRP) Therapy for Rheumatology
Table 17    Platelet Rich Plasma (PRP) Therapy Market Size for Rheumatology, by Country/Region, 2019–2028 (USD Million)
Table 18    List of Research Trials for Dermatology & Cosmetology
Table 19    Key Players offering Platelet Rich Plasma (PRP) Therapy for Dermatology & Cosmetology
Table 20    Platelet Rich Plasma (PRP) Therapy Market Size for Dermatology & Cosmetology, by Country/Region, 2019–2028 (USD Million)
Table 21    Key Player offering Platelet Rich Plasma (PRP) Therapy for Ophthalmology
Table 22    Platelet Rich Plasma (PRP) Therapy Market Size for Ophthalmology, by Country/Region, 2019–2028 (USD Million)
Table 23    Key Player offering Platelet Rich Plasma (PRP) Therapy for Stomatology & Odontology Application
Table 24    Platelet Rich Plasma (PRP) Therapy Market Size for Stomatology & Odontology, by Country/Region, 2019–2028 (USD Million)
Table 25    Clinical Trials with PRP Therapy in Other Applications
Table 26    Key Players offering Platelet Rich Plasma (PRP) Therapy for Other Applications
Table 27    Platelet Rich Plasma (PRP) Therapy Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 28    Global Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 29    Global Platelet Rich Plasma Therapy Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 30    Various Ongoing Researches for Platelet Rich Plasma
Table 31    Global Platelet Rich Plasma Therapy Market Size for Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 32    Global Platelet-Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33    North America: Platelet Rich Plasma Therapy Market Size, by Country, 2019–2028 (USD Million)
Table 34    North America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 35    North America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 36    North America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 37    U.S.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 38    U.S.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 39    U.S.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 40    Canada: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 41    Canada: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 42    Canada: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 43    Europe: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 44    Europe: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 45    Europe: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 46    Europe: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 47    Germany: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 48    Germany: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 49    Germany: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 50    France: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 51    France: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 52    France: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 53    U.K.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 54    U.K.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 55    U.K.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 56    Italy: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 57    Italy: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 58    Italy: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 59    Spain: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 60    Spain: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 61    Spain: Platelet Rich Plasma Therapy Market Size, by End User 2019–2028 (USD Million)
Table 62    Fertility Rate total (Birth Per Woman)
Table 63    RoE: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 64    RoE: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 65    RoE: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 66    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 67    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 68    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 69    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 70    Japan: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 71    Japan: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 72    Japan: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 73    China: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 74    China: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 75    China: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 76    India: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 77    India: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 78    India: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 79    RoAPAC: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 80    RoAPAC: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 81    RoAPAC: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 82    Health Expenditure Per Capita In Latin American Countries
Table 83    Latin America: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84    Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 85    Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 86    Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 87    Brazil: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 88    Brazil: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 89    Brazil: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 90    Mexico: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 91    Mexico: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 92    Mexico: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 93    Argentina: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 94    Argentina: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 95    Argentina: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 96    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 97    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 98    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 99    Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 100    Middle East & Africa Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 101    Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 102    Number of Developments by the Major Players During 2018–2021
Table 103    Few Authorities/Organizations Providing Funding/Grants for Blood-Related Research
Table 104    Grants/Fundings by Various Institutions and Organisations for PRP Studies and Research

List of Figures

Figure 1    Research Process
Figure 2    Key Secondary Sources
Figure 3    Primary Research Techniques
Figure 4    Key Executives Interviewed
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6    Market Size Estimation
Figure 7    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9    Global Platelet Rich Plasma (PRP) Therapy Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 10    Platelet Rich Plasma (PRP) Therapy Market Size, by Geography
Figure 11    Market Dynamics
Figure 12    Porter’s Five forces Analysis: Platelet Rich Plasma Therapy Market
Figure 13    Global Platelet Rich Plasma Therapy Market Size, by Type, 2021-2028 (USD Million)
Figure 14    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 15    Global Platelet Rich Plasma Therapy Market Size, by End User, 2021–2028 (USD Million)
Figure 16    Number of Research Published over The Years for Platelet Rich Plasma Therapy
Figure 17    Global Platelet Rich Plasma Therapy Market Size, by Geography, 2021–2028 (USD Million)
Figure 18    North America: Platelet Rich Plasma Therapy Market Snapshot
Figure 19    Europe: Platelet Rich Plasma Therapy Market Snapshot
Figure 20    Asia-Pacific: Platelet Rich Plasma Therapy Market Snapshot
Figure 21    Key Growth Strategies Adopted by Leading Players -2018–2021
Figure 22    Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Application
Figure 23    Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Geography
Figure 24    Market Share Analysis: Platelet Rich Plasma (PRP) Therapy Industry, 2020
Figure 30    National Institute of Health, U.S. Funding for Regenerative Medicines, 2013–2022 (USD Million)
Figure 31    Johnson And Johnson: Financial Overview, 2020
Figure 32    Terumo Corporation.: Financial Overview, 2020
Figure 33    Stryker Corporation.: Financial Overview, 2020
Figure 34    Zimmer Biomet Holdings, Inc: Financial Overview, 2020

 
Name can only consist of alphabets.
Please provide your full name.
 
Please provide valid email address.
Please provide your email address.
 
Please provide your job title.
 
Please provide your company name.
 
Please provide your company name.
 
Please provide valid phone number.
Please provide your phone number.
 
Please enter minimum 10 characters.
 
Please enter Captcha.
Please enter valid Captcha.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Related Research

The Plasma Therapy Market is expected to grow at a CAGR of 12.2% during the forecast period to reach $882.5 million by 2028. The growth of this market is mainly attributed to factors such as the advantages offered by PRP treatment, increasing awareness towards PRP therapies; the rising prevalence of musculoskeletal, sports, & orthopedic injuries; and the growing number of cosmetic procedures worldwide.

In addition, increasing PRP treatments and advancing healthcare in emerging economies are likely to offer significant growth opportunities for platelet rich plasma therapy providers.

However, the availability of alternatives for PRP treatment and side-effects associated with PRP is expected to restrain the growth of the platelet rich plasma therapy market to some extent during the forecast period. Also, the stringent regulatory framework for PRP use is the major challenging factor observed in this market.

Plasma Therapy Market

                                                                     Click here to: Get Free Sample Pages of this Report 

Impact of COVID-19 Pandemic on the Plasma Therapy Market

The outbreak of the COVID-19 pandemic and the lockdowns implemented by governments to control the spread of the disease impacted various industries. The upsurge of COVID-19 infected patients affected the management of hospitals due to its limited resources and staff compared to the sudden growth in the number of infected patients, which led to a delay in some of the surgeries and medical procedures. The procedures that were not life-threatening were delayed, and medical procedures that would have severely impacted patients and even caused loss of life if not carried out were prioritized.

The platelet-rich plasma (PRP) is mainly used in cosmetics, dermatology, orthopedics, dental procedures & oral surgeries, and sports medicine. The disorders and treatments associated with these problems are usually non-life-threatening. Therefore, PRP treatments to patients with these medical requirements were not prioritized. For instance, according to the American Society of Plastic Surgeons (ASPS), the PRP procedures for cosmetics in the U.S. fell to 231,140 procedures in 2020, from 275,101 procedures in 2019, with a decline of 16%.

Manufacturers, business owners, and suppliers of PRP therapy products within Asian economies were impacted severely by the rapid growth in the number of patients. During the outbreak, low- and middle-income countries faced more challenges due to underdeveloped health infrastructures and restrictions imposed by the authorities on suppliers and industries. The pandemic led to a significant decrease in PRP demand in regenerative medicine and pain management such as, tennis elbow, arthritis, torn ligaments, and cosmetic & plastic surgeries.

 Lockdowns were implemented worldwide to stop the transmission of the disease. The implementation of lockdown and other preventative measures impacted the supply chain and the availability of medical devices. It also affected the revenue of the companies and led to an increase in unemployment. For instance, according to a statement given by Tricell Bio, a manufacturer of PRP kits based in India, COVID-19 has impacted the business across all the industries and hopes to recover from the setback soon.

The COVID-19 outbreak severely impacted the countries in the Southeast Asian region as several countries from this region depend on export and tourism for revenue generation. Also, medical tourism suffered significant losses due to travel restrictions. For instance, according to the Malaysian Health Tourism Council (MHTC), medical tourism in the country reported a decline by 75% in revenues in 2020 ($120 million) compared to 2019. The negative impact on health tourism due to the pandemic resulted in the decrease in the adoption of PRP treatments, decreasing the usage of PRP products.

Key Findings in the Global Plasma Therapy Market Study

The Leukocyte-rich PRP Segment Expected to Grow at the Highest CAGR During Forecast Period

Based on type, the global platelet rich plasma market is segmented into pure PRP, leukocyte–rich PRP, pure platelet-rich fibrin, and leukocyte and platelet rich fibrin. In 2021, the pure PRP segment is estimated to account for the largest share of the global platelet rich plasma therapy market. Little or no risks associated with pure PRP and its ability to accelerate the healing process of tissue, tendons, and bones are the factors driving the demand for pure PRP in the market. On the other hand, the increasing use of L-PRP in patients suffering from osteoarthritis of the knee and hips and positive effects of L-PRP in certain medical applications for therapeutic purposes are expected to account for the high growth of the leukocyte–rich PRP segment during the forecast period.

The Dermatology and Cosmetology Segment Expected to Grow at the Highest CAGR During Forecast Period

Based on application, the global platelet rich plasma market is segmented into orthopedics & traumatology, rheumatology, dermatology & cosmetology, ophthalmology, stomatology & odontology, and other applications. The dermatology & cosmetology segment is expected to grow at the highest CAGR during the forecast period. The rising number of patients with skin and hair-related conditions, growing beauty consciousness amongst the general population, and increasing adoption of microneedling for cosmetic purposes support the market growth of this segment.

The Hospitals & Clinics Segment Estimated to Account for the Largest Share of Global PRP Therapy Market in 2021

Based on end user, the global platelet rich plasma therapy market is segmented into hospitals & clinics and research institutes. In 2021, the hospitals & clinics segment is estimated to account for a larger share of the global platelet rich plasma therapy market. The large share of this segment is attributed to factors such as the increase in healthcare spending and growing awareness and prescriptions for PRP treatments and procedures to patients for various medical conditions.

North America Estimated to Account for Largest Share of Global PRP Therapy Market in 2021

Based on geography, the PRP therapy market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2021, North America is estimated to account for the largest share of the global PRP therapy market. The region’s largest market share is primarily attributed to the presence of leading platelet rich plasma therapy product manufacturers, growing awareness toward advantages of platelet rich plasma therapies, active involvement of academic and research institutes to conduct advanced research and development, and support from government and regulatory authorities to promote the use of PRP for medical applications.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments that market participants adopted over the past four years. The key players profiled in the global platelet-rich plasma therapy market report include Arthrex, Inc. (U.S.), DePuy Synthes Inc. (U.S.), Dr PRP USA LLC (U.S.), EmCyte Corporation (U.S.), Exactech Inc. (U.S.), Global Stem Cells Group, Inc. (U.S.), Celling Biosciences, Inc. (U.S.), Terumo Corporation (Japan), Regen Lab SA (Switzerland), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), and Juventix Regenerative Medical LLC (U.S.).

Scope of the Report:

Platelet Rich Plasma Therapy Market, by Type

  • Pure Platelet-rich Plasma
  • Leukocyte-rich PRP
  • Platelet-rich Fibrin
  • Leukocyte & Platelet-rich Fibrin

Platelet Rich Plasma Therapy Market, by Application

  • Orthopedics and Traumatology
  • Dermatology and Cosmetology
  • Rheumatology
  • Stomatology and Odontology
  • Ophthalmology
  • Others

Platelet Rich Plasma Therapy Market, by End User

  • Hospitals and Clinics
  • Research Institutes

Platelet Rich Plasma Therapy Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of LATAM (RoLATAM)
  • Middle East & Africa

Key questions answered in the report:

  Request Sample

1.    Introduction
       1.1.    Market Definition
       1.2.    Market Ecosystem
       1.3.    Currency
       1.4.    Key Stakeholders

2.    Research Methodology
       2.1.    Research Process
       2.2.    Data Collection & Validation
                 2.2.1.    Secondary Research
                 2.2.2.    Primary Research
       2.3.    Market Assessment
                 2.3.1.    Market Size Estimation
                              2.3.1.1.    Bottom-Up Approach
                              2.3.1.2.    Top-Down Approach
                              2.3.1.3.    Growth Forecast
                 2.3.2.    Market Share Analysis
       2.4.    Assumptions for this Study
       2.5.    Limitations for the Study

3.    Executive Summary

4.    Market Insights
       4.1.    Drivers
                 4.1.1.    Advantages Offered by PRP Treatment
                 4.1.2.    Increasing Awareness Toward PRP Therapies
                 4.1.3.    Rising Prevalence of Musculoskeletal and Sports Injuries
                 4.1.4.    Growing Number of Cosmetic Procedures Worldwide
       4.2.    Restraints
                 4.2.1.    Availability of Alternatives for PRP Treatment
                 4.2.2.    Side-Effects Associated with the Use of PRP
       4.3.    Opportunities
                 4.3.1.    Increasing Applications of PRP Treatments 
                 4.3.2. Advancing Healthcare in Emerging Economies 
       4.4.    Challenge
                 4.4.1. Stringent Regulatory Framework for the Use of PRP
       4.5.    Porter’s Five Forces Analysis
                 4.5.1.    Bargaining Power of Suppliers
                 4.5.2.    Bargaining Power of Buyers
                 4.5.3.    Threat of Substitutes
                 4.5.4.    Threat of New Entrants
                 4.5.5.    Competitive Rivalry

5.    Impact of COVID-19 on the Global Platelet Rich Plasma Market

6.    PRP Qualification Criteria

7.    PRP Therapy Market Trends

8.    Platelet Rich Plasma Therapy Market, by Type
       8.1.    Introduction
       8.2.    Pure PRP
       8.3.    Leukocyte-Rich PRP
       8.4.    Pure Platelet Rich Fibrin
       8.5.    Leukocyte And Platelet Rich Fibrin (L-PRF)

9.    Platelet Rich Plasma (PRP) Therapy Market, by Application
       9.1.    Introduction
       9.2.    Orthopedics & Traumatology
       9.3.    Rheumatology
       9.4.    Dermatology & Cosmetology
       9.5.    Opthalmology
       9.6.    Stomatology & Odontology
       9.7.    Other Applications

10.   Platelet Rich Plasma Therapy Market, by End User
           10.1.    Introduction
           10.2.    Hospitals & Clinics
           10.3.    Research Institutes

11.    Platet Rich Plasma Therapy Market, by Geography
           11.1.    Introduction
           11.2.    North America
                       11.2.1.    U.S.
                       11.2.2.    Canada
           11.3.    Europe
                       11.3.1.    Germany
                       11.3.2.    France
                       11.3.3.    U.K.                       
                       11.3.4.    Italy
                       11.3.5.    Spain
                       11.3.6.    Rest of Europe (RoE)
           11.4.    Asia-Pacific
                       11.4.1.    Japan
                       11.4.2.    China
                       11.4.3.    India
                       11.4.4.    Rest of Asia-Pacific (RoAPAC)
           11.5.    Latin America
                       11.5.1.    Brazil
                       11.5.2.    Mexico
                       11.5.3.    Argentina
                       11.5.4.    Rest of Latin America
           11.6.    Middle East & Africa

12.    Competitive Landscape
           12.1.    Introduction
           12.2.    Key Growth Strategies
           12.3.    Market Share Analysis (2020)
                      12.3.1.    DePuy Synthes, Inc. (U.S.)
                      12.3.2.    Stryker Corporation (U.S.)
                      12.3.3.    Zimmer Biomet Holdings, Inc. (U.S.)
                      12.3.4.    Terumo Corporation (Japan).
           12.4.    Key Players SWOT Analysis
                      12.4.1.    Zimmer Biomet Holdings, Inc.
                                    12.4.1.1. Strengths
                                    12.4.1.2. Weaknesses
                                    12.4.1.3. Opportunities
                                    12.4.1.4. Threats
                      12.4.2.    Terumo Corporation
                                    12.4.2.1. Strengths
                                    12.4.2.2. Weaknesses
                                    12.4.2.3. Opportunities
                                    12.4.2.4. Threats
                      12.4.3.    Arthrex, Inc.
                                    12.4.3.1. Strengths
                                    12.4.3.2. Weaknesses
                                    12.4.3.3. Opportunities
                                    12.4.3.4. Threats
                       12.4.4.    DePuy Synthes, Inc. (Johnson &Johnson)
                                    12.4.4.1. Strengths
                                    12.4.4.2. Weaknesses
                                    12.4.4.3. Opportunities
                                    12.4.4.4. Threats
                      12.4.5.    Stryker Corporation
                                    12.4.5.1. Strengths
                                    12.4.5.2. Weaknesses
                                    12.4.5.3. Opportunities
                                    12.4.5.4. Threats
           12.5.    Funding and Grants Assessment

13.    Company Profiles
           13.1.    Arthrex, Inc.
                     13.1.1.    Business Overview
                     13.1.2.    Product Portfolio
                     13.1.3.    Strategic Developments
           13.2.   DePuy Synthes, Inc. (Johnson &  Johnson)
                     13.2.1.    Business Overview
                     13.2.2.    Financial Overview
                     13.2.3.    Product Portfolio
           13.3.    Dr PRP USA LLC
                     13.3.1.    Business Overview
                     13.3.2.    Product Portfolio
           13.4.   Emcyte Corporation
                     13.4.1.    Business Overview
                     13.4.2.    Product Portfolio
                     13.4.3.    Strategic Developments
           13.5.   Exactech, Inc.
                     13.5.1.    Business Overview
                     13.5.2.    Financial Overview
                     13.5.3.    Product Portfolio
           13.6.   Global Stem Cells Group, Inc.
                     13.6.1.    Business Overview
                     13.6.2.    Product Portfolio
                     13.6.3.    Strategic Developments
           13.7.   Celling Biosciences, Inc
                     13.7.1.    Business Overview
                     13.7.2.    Product Portfolio
           13.8.   Terumo Corporation
                     13.8.1.    Business Overview
                     13.8.2.    Financial Overview
                     13.8.3.    Product Portfolio
           13.9.   Regen Lab SA
                     13.9.1.    Business Overview
                     13.9.2.    Product Portfolio
           13.10.  Stryker Corporation
                     13.10.1.    Business Overview
                     13.10.2.    Financial Overview
                     13.10.3.    Product Portfolio
                     13.10.4.    Strategic Developments
           13.11. Zimmer Biomet Holdings, Inc.
                     13.11.1.    Business Overview
                     13.11.2.    Financial Overview
                     13.11.3.    Product Portfolio
           13.12.  Juventix Regenerative Medical, Llc
                     13.12.1.    Business Overview
                     13.12.2.    Product Portfolio

14.    Appendix
           14.1.    Questionnaire
           14.2.    Available Customization

List of Tables

Table 1    Platelet Rich Plasma (PRP) Therapy Market Drivers: Impact Analysis (2021–2028)
Table 2    Top Five Non-Surgical Cosmetic Procedures Performed Worldwide In 2019 and Change As Compared to 2018:
Table 3    Platelet Rich Plasma (PRP) Therapy Market Restraints: Impact Analysis (2021–2028)
Table 4    Products and Their PRP Concentrations of Some of The Leading Companies in the PRP Therapy Market
Table 5    Current Indications for Which PRP Therapy Is Used
Table 6    Ongoing Research in New Medical Fields Regarding PRP Therapy
Table 7    Global Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 8    Global Pure PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9    Global Leukocyte-Rich PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 10    Global Pure Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11    Global Leukocyte and Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 13    List of Clinical Trials with PRP for Orthopedic Applications
Table 14    Key Players offering Platelet Rich Plasma (PRP) Therapy for Orthopedics & Traumatology
Table 15    Platelet Rich Plasma (PRP) Therapy Market Size for Orthopedics & Traumatology, by Country/Region, 2019–2028 (USD Million)
Table 16    Key Players offering Platelet Rich Plasma (PRP) Therapy for Rheumatology
Table 17    Platelet Rich Plasma (PRP) Therapy Market Size for Rheumatology, by Country/Region, 2019–2028 (USD Million)
Table 18    List of Research Trials for Dermatology & Cosmetology
Table 19    Key Players offering Platelet Rich Plasma (PRP) Therapy for Dermatology & Cosmetology
Table 20    Platelet Rich Plasma (PRP) Therapy Market Size for Dermatology & Cosmetology, by Country/Region, 2019–2028 (USD Million)
Table 21    Key Player offering Platelet Rich Plasma (PRP) Therapy for Ophthalmology
Table 22    Platelet Rich Plasma (PRP) Therapy Market Size for Ophthalmology, by Country/Region, 2019–2028 (USD Million)
Table 23    Key Player offering Platelet Rich Plasma (PRP) Therapy for Stomatology & Odontology Application
Table 24    Platelet Rich Plasma (PRP) Therapy Market Size for Stomatology & Odontology, by Country/Region, 2019–2028 (USD Million)
Table 25    Clinical Trials with PRP Therapy in Other Applications
Table 26    Key Players offering Platelet Rich Plasma (PRP) Therapy for Other Applications
Table 27    Platelet Rich Plasma (PRP) Therapy Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 28    Global Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 29    Global Platelet Rich Plasma Therapy Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 30    Various Ongoing Researches for Platelet Rich Plasma
Table 31    Global Platelet Rich Plasma Therapy Market Size for Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 32    Global Platelet-Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33    North America: Platelet Rich Plasma Therapy Market Size, by Country, 2019–2028 (USD Million)
Table 34    North America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 35    North America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 36    North America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 37    U.S.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 38    U.S.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 39    U.S.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 40    Canada: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 41    Canada: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 42    Canada: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 43    Europe: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 44    Europe: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 45    Europe: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 46    Europe: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 47    Germany: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 48    Germany: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 49    Germany: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 50    France: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 51    France: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 52    France: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 53    U.K.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 54    U.K.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 55    U.K.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 56    Italy: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 57    Italy: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 58    Italy: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 59    Spain: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 60    Spain: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 61    Spain: Platelet Rich Plasma Therapy Market Size, by End User 2019–2028 (USD Million)
Table 62    Fertility Rate total (Birth Per Woman)
Table 63    RoE: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 64    RoE: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 65    RoE: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 66    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 67    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 68    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 69    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 70    Japan: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 71    Japan: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 72    Japan: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 73    China: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 74    China: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 75    China: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 76    India: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 77    India: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 78    India: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 79    RoAPAC: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 80    RoAPAC: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 81    RoAPAC: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 82    Health Expenditure Per Capita In Latin American Countries
Table 83    Latin America: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84    Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 85    Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 86    Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 87    Brazil: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 88    Brazil: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 89    Brazil: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 90    Mexico: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 91    Mexico: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 92    Mexico: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 93    Argentina: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 94    Argentina: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 95    Argentina: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 96    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 97    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 98    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 99    Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 100    Middle East & Africa Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 101    Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 102    Number of Developments by the Major Players During 2018–2021
Table 103    Few Authorities/Organizations Providing Funding/Grants for Blood-Related Research
Table 104    Grants/Fundings by Various Institutions and Organisations for PRP Studies and Research

List of Figures

Figure 1    Research Process
Figure 2    Key Secondary Sources
Figure 3    Primary Research Techniques
Figure 4    Key Executives Interviewed
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6    Market Size Estimation
Figure 7    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9    Global Platelet Rich Plasma (PRP) Therapy Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 10    Platelet Rich Plasma (PRP) Therapy Market Size, by Geography
Figure 11    Market Dynamics
Figure 12    Porter’s Five forces Analysis: Platelet Rich Plasma Therapy Market
Figure 13    Global Platelet Rich Plasma Therapy Market Size, by Type, 2021-2028 (USD Million)
Figure 14    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 15    Global Platelet Rich Plasma Therapy Market Size, by End User, 2021–2028 (USD Million)
Figure 16    Number of Research Published over The Years for Platelet Rich Plasma Therapy
Figure 17    Global Platelet Rich Plasma Therapy Market Size, by Geography, 2021–2028 (USD Million)
Figure 18    North America: Platelet Rich Plasma Therapy Market Snapshot
Figure 19    Europe: Platelet Rich Plasma Therapy Market Snapshot
Figure 20    Asia-Pacific: Platelet Rich Plasma Therapy Market Snapshot
Figure 21    Key Growth Strategies Adopted by Leading Players -2018–2021
Figure 22    Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Application
Figure 23    Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Geography
Figure 24    Market Share Analysis: Platelet Rich Plasma (PRP) Therapy Industry, 2020
Figure 30    National Institute of Health, U.S. Funding for Regenerative Medicines, 2013–2022 (USD Million)
Figure 31    Johnson And Johnson: Financial Overview, 2020
Figure 32    Terumo Corporation.: Financial Overview, 2020
Figure 33    Stryker Corporation.: Financial Overview, 2020
Figure 34    Zimmer Biomet Holdings, Inc: Financial Overview, 2020

  Request Sample

1.    Introduction
       1.1.    Market Definition
       1.2.    Market Ecosystem
       1.3.    Currency
       1.4.    Key Stakeholders

2.    Research Methodology
       2.1.    Research Process
       2.2.    Data Collection & Validation
                 2.2.1.    Secondary Research
                 2.2.2.    Primary Research
       2.3.    Market Assessment
                 2.3.1.    Market Size Estimation
                              2.3.1.1.    Bottom-Up Approach
                              2.3.1.2.    Top-Down Approach
                              2.3.1.3.    Growth Forecast
                 2.3.2.    Market Share Analysis
       2.4.    Assumptions for this Study
       2.5.    Limitations for the Study

3.    Executive Summary

4.    Market Insights
       4.1.    Drivers
                 4.1.1.    Advantages Offered by PRP Treatment
                 4.1.2.    Increasing Awareness Toward PRP Therapies
                 4.1.3.    Rising Prevalence of Musculoskeletal and Sports Injuries
                 4.1.4.    Growing Number of Cosmetic Procedures Worldwide
       4.2.    Restraints
                 4.2.1.    Availability of Alternatives for PRP Treatment
                 4.2.2.    Side-Effects Associated with the Use of PRP
       4.3.    Opportunities
                 4.3.1.    Increasing Applications of PRP Treatments 
                 4.3.2. Advancing Healthcare in Emerging Economies 
       4.4.    Challenge
                 4.4.1. Stringent Regulatory Framework for the Use of PRP
       4.5.    Porter’s Five Forces Analysis
                 4.5.1.    Bargaining Power of Suppliers
                 4.5.2.    Bargaining Power of Buyers
                 4.5.3.    Threat of Substitutes
                 4.5.4.    Threat of New Entrants
                 4.5.5.    Competitive Rivalry

5.    Impact of COVID-19 on the Global Platelet Rich Plasma Market

6.    PRP Qualification Criteria

7.    PRP Therapy Market Trends

8.    Platelet Rich Plasma Therapy Market, by Type
       8.1.    Introduction
       8.2.    Pure PRP
       8.3.    Leukocyte-Rich PRP
       8.4.    Pure Platelet Rich Fibrin
       8.5.    Leukocyte And Platelet Rich Fibrin (L-PRF)

9.    Platelet Rich Plasma (PRP) Therapy Market, by Application
       9.1.    Introduction
       9.2.    Orthopedics & Traumatology
       9.3.    Rheumatology
       9.4.    Dermatology & Cosmetology
       9.5.    Opthalmology
       9.6.    Stomatology & Odontology
       9.7.    Other Applications

10.   Platelet Rich Plasma Therapy Market, by End User
           10.1.    Introduction
           10.2.    Hospitals & Clinics
           10.3.    Research Institutes

11.    Platet Rich Plasma Therapy Market, by Geography
           11.1.    Introduction
           11.2.    North America
                       11.2.1.    U.S.
                       11.2.2.    Canada
           11.3.    Europe
                       11.3.1.    Germany
                       11.3.2.    France
                       11.3.3.    U.K.                       
                       11.3.4.    Italy
                       11.3.5.    Spain
                       11.3.6.    Rest of Europe (RoE)
           11.4.    Asia-Pacific
                       11.4.1.    Japan
                       11.4.2.    China
                       11.4.3.    India
                       11.4.4.    Rest of Asia-Pacific (RoAPAC)
           11.5.    Latin America
                       11.5.1.    Brazil
                       11.5.2.    Mexico
                       11.5.3.    Argentina
                       11.5.4.    Rest of Latin America
           11.6.    Middle East & Africa

12.    Competitive Landscape
           12.1.    Introduction
           12.2.    Key Growth Strategies
           12.3.    Market Share Analysis (2020)
                      12.3.1.    DePuy Synthes, Inc. (U.S.)
                      12.3.2.    Stryker Corporation (U.S.)
                      12.3.3.    Zimmer Biomet Holdings, Inc. (U.S.)
                      12.3.4.    Terumo Corporation (Japan).
           12.4.    Key Players SWOT Analysis
                      12.4.1.    Zimmer Biomet Holdings, Inc.
                                    12.4.1.1. Strengths
                                    12.4.1.2. Weaknesses
                                    12.4.1.3. Opportunities
                                    12.4.1.4. Threats
                      12.4.2.    Terumo Corporation
                                    12.4.2.1. Strengths
                                    12.4.2.2. Weaknesses
                                    12.4.2.3. Opportunities
                                    12.4.2.4. Threats
                      12.4.3.    Arthrex, Inc.
                                    12.4.3.1. Strengths
                                    12.4.3.2. Weaknesses
                                    12.4.3.3. Opportunities
                                    12.4.3.4. Threats
                       12.4.4.    DePuy Synthes, Inc. (Johnson &Johnson)
                                    12.4.4.1. Strengths
                                    12.4.4.2. Weaknesses
                                    12.4.4.3. Opportunities
                                    12.4.4.4. Threats
                      12.4.5.    Stryker Corporation
                                    12.4.5.1. Strengths
                                    12.4.5.2. Weaknesses
                                    12.4.5.3. Opportunities
                                    12.4.5.4. Threats
           12.5.    Funding and Grants Assessment

13.    Company Profiles
           13.1.    Arthrex, Inc.
                     13.1.1.    Business Overview
                     13.1.2.    Product Portfolio
                     13.1.3.    Strategic Developments
           13.2.   DePuy Synthes, Inc. (Johnson &  Johnson)
                     13.2.1.    Business Overview
                     13.2.2.    Financial Overview
                     13.2.3.    Product Portfolio
           13.3.    Dr PRP USA LLC
                     13.3.1.    Business Overview
                     13.3.2.    Product Portfolio
           13.4.   Emcyte Corporation
                     13.4.1.    Business Overview
                     13.4.2.    Product Portfolio
                     13.4.3.    Strategic Developments
           13.5.   Exactech, Inc.
                     13.5.1.    Business Overview
                     13.5.2.    Financial Overview
                     13.5.3.    Product Portfolio
           13.6.   Global Stem Cells Group, Inc.
                     13.6.1.    Business Overview
                     13.6.2.    Product Portfolio
                     13.6.3.    Strategic Developments
           13.7.   Celling Biosciences, Inc
                     13.7.1.    Business Overview
                     13.7.2.    Product Portfolio
           13.8.   Terumo Corporation
                     13.8.1.    Business Overview
                     13.8.2.    Financial Overview
                     13.8.3.    Product Portfolio
           13.9.   Regen Lab SA
                     13.9.1.    Business Overview
                     13.9.2.    Product Portfolio
           13.10.  Stryker Corporation
                     13.10.1.    Business Overview
                     13.10.2.    Financial Overview
                     13.10.3.    Product Portfolio
                     13.10.4.    Strategic Developments
           13.11. Zimmer Biomet Holdings, Inc.
                     13.11.1.    Business Overview
                     13.11.2.    Financial Overview
                     13.11.3.    Product Portfolio
           13.12.  Juventix Regenerative Medical, Llc
                     13.12.1.    Business Overview
                     13.12.2.    Product Portfolio

14.    Appendix
           14.1.    Questionnaire
           14.2.    Available Customization

List of Tables

Table 1    Platelet Rich Plasma (PRP) Therapy Market Drivers: Impact Analysis (2021–2028)
Table 2    Top Five Non-Surgical Cosmetic Procedures Performed Worldwide In 2019 and Change As Compared to 2018:
Table 3    Platelet Rich Plasma (PRP) Therapy Market Restraints: Impact Analysis (2021–2028)
Table 4    Products and Their PRP Concentrations of Some of The Leading Companies in the PRP Therapy Market
Table 5    Current Indications for Which PRP Therapy Is Used
Table 6    Ongoing Research in New Medical Fields Regarding PRP Therapy
Table 7    Global Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 8    Global Pure PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 9    Global Leukocyte-Rich PRP Market Size, by Country/Region, 2019–2028 (USD Million)
Table 10    Global Pure Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 11    Global Leukocyte and Platelet Rich Fibrin Market Size, by Country/Region, 2019–2028 (USD Million)
Table 12    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 13    List of Clinical Trials with PRP for Orthopedic Applications
Table 14    Key Players offering Platelet Rich Plasma (PRP) Therapy for Orthopedics & Traumatology
Table 15    Platelet Rich Plasma (PRP) Therapy Market Size for Orthopedics & Traumatology, by Country/Region, 2019–2028 (USD Million)
Table 16    Key Players offering Platelet Rich Plasma (PRP) Therapy for Rheumatology
Table 17    Platelet Rich Plasma (PRP) Therapy Market Size for Rheumatology, by Country/Region, 2019–2028 (USD Million)
Table 18    List of Research Trials for Dermatology & Cosmetology
Table 19    Key Players offering Platelet Rich Plasma (PRP) Therapy for Dermatology & Cosmetology
Table 20    Platelet Rich Plasma (PRP) Therapy Market Size for Dermatology & Cosmetology, by Country/Region, 2019–2028 (USD Million)
Table 21    Key Player offering Platelet Rich Plasma (PRP) Therapy for Ophthalmology
Table 22    Platelet Rich Plasma (PRP) Therapy Market Size for Ophthalmology, by Country/Region, 2019–2028 (USD Million)
Table 23    Key Player offering Platelet Rich Plasma (PRP) Therapy for Stomatology & Odontology Application
Table 24    Platelet Rich Plasma (PRP) Therapy Market Size for Stomatology & Odontology, by Country/Region, 2019–2028 (USD Million)
Table 25    Clinical Trials with PRP Therapy in Other Applications
Table 26    Key Players offering Platelet Rich Plasma (PRP) Therapy for Other Applications
Table 27    Platelet Rich Plasma (PRP) Therapy Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 28    Global Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 29    Global Platelet Rich Plasma Therapy Market Size for Hospitals & Clinics, by Country/Region, 2019–2028 (USD Million)
Table 30    Various Ongoing Researches for Platelet Rich Plasma
Table 31    Global Platelet Rich Plasma Therapy Market Size for Research Institutes, by Country/Region, 2019–2028 (USD Million)
Table 32    Global Platelet-Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33    North America: Platelet Rich Plasma Therapy Market Size, by Country, 2019–2028 (USD Million)
Table 34    North America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 35    North America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 36    North America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 37    U.S.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 38    U.S.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 39    U.S.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 40    Canada: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 41    Canada: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 42    Canada: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 43    Europe: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 44    Europe: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 45    Europe: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 46    Europe: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 47    Germany: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 48    Germany: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 49    Germany: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 50    France: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 51    France: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 52    France: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 53    U.K.: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 54    U.K.: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 55    U.K.: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 56    Italy: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 57    Italy: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 58    Italy: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 59    Spain: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 60    Spain: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 61    Spain: Platelet Rich Plasma Therapy Market Size, by End User 2019–2028 (USD Million)
Table 62    Fertility Rate total (Birth Per Woman)
Table 63    RoE: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 64    RoE: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 65    RoE: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 66    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 67    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 68    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 69    Asia-Pacific: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 70    Japan: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 71    Japan: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 72    Japan: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 73    China: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 74    China: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 75    China: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 76    India: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 77    India: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 78    India: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 79    RoAPAC: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 80    RoAPAC: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 81    RoAPAC: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 82    Health Expenditure Per Capita In Latin American Countries
Table 83    Latin America: Platelet Rich Plasma Therapy Market Size, by Country/Region, 2019–2028 (USD Million)
Table 84    Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 85    Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 86    Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 87    Brazil: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 88    Brazil: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 89    Brazil: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 90    Mexico: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 91    Mexico: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 92    Mexico: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 93    Argentina: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 94    Argentina: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 95    Argentina: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 96    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 97    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 98    Rest of Latin America: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 99    Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by Type, 2019–2028 (USD Million)
Table 100    Middle East & Africa Platelet Rich Plasma Therapy Market Size, by Application, 2019–2028 (USD Million)
Table 101    Middle East & Africa: Platelet Rich Plasma Therapy Market Size, by End User, 2019–2028 (USD Million)
Table 102    Number of Developments by the Major Players During 2018–2021
Table 103    Few Authorities/Organizations Providing Funding/Grants for Blood-Related Research
Table 104    Grants/Fundings by Various Institutions and Organisations for PRP Studies and Research

List of Figures

Figure 1    Research Process
Figure 2    Key Secondary Sources
Figure 3    Primary Research Techniques
Figure 4    Key Executives Interviewed
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6    Market Size Estimation
Figure 7    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 8    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Type, 2021 Vs. 2028 (USD Million)
Figure 9    Global Platelet Rich Plasma (PRP) Therapy Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 10    Platelet Rich Plasma (PRP) Therapy Market Size, by Geography
Figure 11    Market Dynamics
Figure 12    Porter’s Five forces Analysis: Platelet Rich Plasma Therapy Market
Figure 13    Global Platelet Rich Plasma Therapy Market Size, by Type, 2021-2028 (USD Million)
Figure 14    Global Platelet Rich Plasma (PRP) Therapy Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 15    Global Platelet Rich Plasma Therapy Market Size, by End User, 2021–2028 (USD Million)
Figure 16    Number of Research Published over The Years for Platelet Rich Plasma Therapy
Figure 17    Global Platelet Rich Plasma Therapy Market Size, by Geography, 2021–2028 (USD Million)
Figure 18    North America: Platelet Rich Plasma Therapy Market Snapshot
Figure 19    Europe: Platelet Rich Plasma Therapy Market Snapshot
Figure 20    Asia-Pacific: Platelet Rich Plasma Therapy Market Snapshot
Figure 21    Key Growth Strategies Adopted by Leading Players -2018–2021
Figure 22    Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Application
Figure 23    Platelet Rich Plasma (PRP) Therapy: Competitive Benchmarking by Geography
Figure 24    Market Share Analysis: Platelet Rich Plasma (PRP) Therapy Industry, 2020
Figure 30    National Institute of Health, U.S. Funding for Regenerative Medicines, 2013–2022 (USD Million)
Figure 31    Johnson And Johnson: Financial Overview, 2020
Figure 32    Terumo Corporation.: Financial Overview, 2020
Figure 33    Stryker Corporation.: Financial Overview, 2020
Figure 34    Zimmer Biomet Holdings, Inc: Financial Overview, 2020

  Request Sample
Related Research